Related Experiment Video
Updated: Jul 5, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Oxidative stress, inflammation and cardiovascular disease in chronic renal failure
Santina Cottone1, Maria Carmela Lorito, Raffaella Riccobene
1Chair of Nephrology and Unit of Renal Diseases and Hypertension, University of Palermo, Palermo, Italy. sancott@tin.it
Abstract:
Traditional risk factors such as hypertension, diabetes, dyslipidemia, obesity and metabolic syndrome, as well as additional nontraditional risk factors, can damage the kidney directly and by promoting intrarenal atherogenesis. Evidence indicates that increased oxidative stress and inflammation may mediate most of the effects of risk factors on the kidney. Clinical studies have demonstrated a relationship between oxidative stress and inflammatory biomarkers, and a few studies indicate an inverse correlation of oxidative stress biomarkers with estimated glomerular filtration rate (eGFR). Further, surrogate indexes of atherosclerosis such as intima-media thickness and aortic pulse wave velocity have been demonstrated to be related to plasma concentrations of markers of endothelial activation, inflammation and fibrosis in patients with different stages of chronic kidney disease (CKD). Moreover, plasma concentrations of high-sensitivity C-reactive protein have been shown to be increased and related to left ventricular mass in CKD individuals having left ventricular hypertrophy. In contrast, in these patients, decreases in fetuin-A plasma levels have been reported. Considering the complex background of the pathophysiological changes characterizing CKD patients, we can consider cardiovascular disease a multifactorial complication of CKD.
Insights
Traditional and nontraditional risk factors harm kidneys via oxidative stress and inflammation. These factors are linked to reduced kidney function (eGFR) and cardiovascular disease in chronic kidney disease (CKD) patients.
Area of Science:
- Nephrology
- Cardiology
- Pathophysiology
Background:
- Traditional risk factors (hypertension, diabetes, dyslipidemia, obesity, metabolic syndrome) and nontraditional factors contribute to kidney damage.
- Oxidative stress and inflammation are key mediators of risk factor effects on the kidney.
- These processes are implicated in intrarenal atherogenesis and cardiovascular complications in chronic kidney disease (CKD).
Purpose of the Study:
- To explore the relationship between traditional and nontraditional risk factors and kidney damage.
- To investigate the role of oxidative stress and inflammation in mediating these effects.
- To understand the link between CKD, atherosclerosis, and cardiovascular disease.
Main Methods:
- Review of clinical studies examining risk factors, oxidative stress, inflammation, and kidney function markers.
- Analysis of associations between biomarkers of oxidative stress, inflammation, endothelial activation, and fibrosis with CKD.
- Examination of cardiovascular markers like left ventricular mass and plasma fetuin-A levels in CKD patients.
Main Results:
- Oxidative stress and inflammatory biomarkers correlate with reduced estimated glomerular filtration rate (eGFR).
- Atherosclerosis surrogate indexes relate to markers of endothelial activation, inflammation, and fibrosis in CKD.
- Increased high-sensitivity C-reactive protein and decreased fetuin-A are observed in CKD patients with left ventricular hypertrophy.
Conclusions:
- Cardiovascular disease is a multifactorial complication of CKD.
- Oxidative stress and inflammation play significant roles in the pathophysiology of CKD and its cardiovascular sequelae.
- Risk factor management is crucial for mitigating kidney damage and cardiovascular risk in CKD.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury II: Pathophysiology
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Kidney Disease IV: Nursing Management
